J&J premieres drug release contact lenses at CIIE

By Sun Chi in Shanghai | chinadaily.com.cn | Updated: 2021-11-08 14:10

Share - WeChat

Daratumumab Injection. [Photo provided to chinadaily.com.cn]

In the drug field, Daratumumab is among the major five products introduced in the Chinese market during the CIIE. The injection is the only drug presently approved by China for treating primary light chain amyloidosis, a rare disease.

|<< Previous 1 2 3 4 5 Next >>|

Previous 3/5 Next

Related Stories

Photo

Tourists gravitate to color floral seas throughout China

Heavy vehicle maker ramps up production to meet overseas demand

Li ethnic culture takes center stage at Hainan Fashion Week

Canton Fair sees surge in overseas buyers

Night economy booms in Nanning

'She-economy' unleashes market potential at consumer expo

Most Viewed in 24 Hours

State Council News

Chinese premier stresses construction of capital market

24 Solar Terms: Grain Rain

Top 10

Top 10 intl travel destinations for Chinese rich

Business focus

Medtech company continues expansion in China

Entrepreneurs gear up for further Sino-German cooperation

China Data

2023 Sino-German investment and trade in numbers

SOEs

SOE profits, share value prioritized

Pillar rock in midstream

Special

Boao Forum 2024

Promoting high-quality development

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349